NCT01486381
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa
- Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa
Clinical trial condition
Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.
NCT01486381
NCT01527539
NCT00617565
NCT01704378
NCT00184639
NCT01024218
NCT01527565
NCT00605137
NCT01697631